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A B S T R A C T
Objectives: An increase in non-toxigenic Corynebacterium diphtheriae infections – mainly invasive
infections – has been observed in countries with high vaccination coverage. However, reasons for this
situation are unknown. In this study we characterized and compared human clinical isolates of non-
toxigenic C. diphtheriae strains isolated from infections that have occurred over recent years and C.
diphtheriae strains isolated from diphtheria cases from past outbreaks in Poland.
Methods: We determined biotypes, genotypes, the occurrence of plasmids, and antimicrobial
susceptibilities of 19 clinical C. diphtheriae strains. Genotypes were determined using pulsed-ﬁeld gel
electrophoresis (PFGE) and enterobacterial repetitive intergenic consensus polymerase chain reaction
(ERIC-PCR) techniques.
Results: The non-toxigenic C. diphtheriae strains isolated over the last few years were found to belong to
biotype gravis and were genetically indistinguishable using PFGE and ERIC-PCR techniques. No plasmids
were detected in the strains. All tested strains were susceptible to penicillin and erythromycin, as well as
to imipenem, vancomycin, daptomycin, gentamicin, tetracycline, clindamycin, trimethoprim/sulfameth-
oxazole, rifampin, quinupristin/dalfopristin, and linezolid. Of the strains tested, 47% were intermediate
for cefotaxime.
Conclusions: The genetic similarity of non-toxigenic C. diphtheriae strains causing infection suggests that
the strains represent a single clone. They may possess additional virulence genes in a chromosome,
related with higher pathogenicity and invasiveness. The genetic changes have not been followed by
resistance to antibiotics.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Corynebacterium diphtheriae is the etiologic agent of toxin-
induced classic diphtheria – an acute infectious disease of
humans affecting the upper respiratory tract and occasionally the
skin. The toxin produced by C. diphtheriae also affects other parts
of the body including the heart and nervous system, causing
paralysis and cardiac failure. Diphtheria is rare in countries with
high vaccination coverage. However, an increase in non-
toxigenic C. diphtheriae infections has been observed in many
countries, for example in France,1 Italy,2 Switzerland,3 Germany,4
and Canada.5,6 Probably the most spectacular increase in the
number of non-toxigenic isolates has been observed in England
andWales – from one isolate in 1986 to 294 in the year 2000.7,8 A* Corresponding author. Tel.: +48 22 5421246; fax: +48 22 5421307.
E-mail address: azasada@pzh.gov.pl (A.A. Zasada).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.05.013lot of the recorded cases are of invasive disease. A similar
situation has been observed in Poland since 2004, when the ﬁrst
case of invasive infection due to non-toxigenic C. diphtheriaewas
recorded.9 Since then, non-toxigenic C. diphtheriae strains have
been isolated from infections – mainly invasive infections –
almost every year.
Observations made during recent years point towards non-
toxigenic C. diphtheriae being an important and dangerous
pathogen. The fatality rate in invasive C. diphtheriae infections is
very high. Patey et al.1 stated that in France between 1987 and
1993 the fatality rate of C. diphtheriae infections was 36%, despite
speciﬁc antibiotic treatment. These observations, together with
increased international travel, show the necessity of monitoring
the spread of C. diphtheriae strains, not only those that are toxigenic
but also non-toxigenic strains.
The aim of this study was to characterize human clinical
isolates of C. diphtheriae isolated from diphtheria cases of past
outbreaks and non-toxigenic isolates from infections that haveses. Published by Elsevier Ltd. All rights reserved.
Table 1
Characteristic of tested Corynebacterium diphtheriae strains
Strain Year of isolation Region of origin Site of isolation Biotype Toxigenicity
(Elek test)
tox gene PCR PFGE types ERIC-PCR types
1/A 1960s ND Nasopharynx mitis + + C X
2/A 1960s ND Nasopharynx mitis + + C1 X
3/A 1960s ND Nasopharynx mitis + + C X
4/A 1960s ND Nasopharynx intermedius + + H XI
5/A 1960s ND Nasopharynx gravis + + G IV
6/B 1990s Otmucho´w Nasopharynx gravis   F VII
7/B 1990s ND Nasopharynx mitis + + B1 I
8/B 1990s ND Nasopharynx intermedius + + B III
9/B 1990s ND Nasopharynx mitis + + B II
10/C 2000 Suwałki Nasopharynx belfanti   E VIII
11/D 2001 Suwałki Nasopharynx belfanti   D IX
12/E 2004 Warszawa Blood gravis   A2 V
13/E 2006 Bydgoszcz Blood gravis   A V
14/E 2007 Gdynia Blood gravis   A V
15/E 2007 Bydgoszcz Wound gravis   A V
16/E 2007 Warszawa Fistula gravis   A V
17/E 2007 Bydgoszcz Wound gravis   A1 VI
18/E 2007 Gdynia Blood gravis   A V
19/E 2008 Rzeszo´w Blood gravis   A V
PCR, polymerase chain reaction; PFGE, pulsed-ﬁeld gel electrophoresis; ERIC, enterobacterial repetitive intergenic consensus; ND, not determined.
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these two groups of strains.
Materials and methods
Bacterial strains
Nineteen C. diphtheriae isolates were investigated. Ten
isolates were from past outbreaks (ﬁve isolated in the 1960 s
and the remaining during 1990–2000); all these isolates were
from the nasopharynx. Eight isolates were from blood and
wound swabs isolated during 2004–2008. One isolate was from
a nose swab isolated in 2001. Details of the tested C. diphtheriae
strains are presented in Table 1. The strains were isolated from
patients in different parts of Poland. No risk factors were
identiﬁed for the infections. All the strains had been stored at
70 8C. Investigated strains were identiﬁed and biotyped
according to the World Health Organization (WHO) guidelines.10
Toxigenicity was tested using standard tests10 and a modiﬁed
Elek test.11 PCR for the tox gene was performed according to
Efstratiou and Maple.10
Pulsed-ﬁeld gel electrophoresis (PFGE)
Bacteria from overnight BHI broth (containing 10% horse
serum and 0.5% glycine) culture were centrifuged and resus-
pended in 100 ml of Tris–EDTA (TE) buffer. An equal volume of
1.2% SeaKem Gold agarose (BMA, USA) was added, and plugs
were cast with a standard casting tray. After the plugs solidiﬁed,
they were incubated in 1 ml of buffer I (1 M NaCl, 10 mM Tris–
HCl pH 7.6, 0.5% sodium deoxycholate, 0.25 M EDTA pH 7.5, 0.5%
sarcosyl, 0.5% Brij 58, 1 mg/ml lysozyme). After overnight
incubation at 37 8C the plugs were washed in TE buffer and
incubated in buffer II (0.25 M EDTA pH 9–9.5, 1% sarcosyl, 50 mg/
ml proteinase K) at 50 8C overnight. The plugs were then washed
several times in TE buffer.
DNA in agarose plugs was digested with SﬁI (Fermentas,
Lithuania), and fragments were separated in 1% pulsed-ﬁeld
certiﬁed agarose (Bio-Rad Laboratories, USA) in 0.5 Tris–borate–
EDTA buffer (pH 8.0) in a CHEF-DR II system (Bio-Rad Laboratories,
USA). The electrophoresis conditions were as described by
De Zoysa et al.12 DNA fragments were photographed over a UV
light after staining with ethidium bromide.Enterobacterial repetitive intergenic consensus polymerase chain
reaction (ERIC-PCR) typing
Total DNA was extracted with the DNeasy Tissue Kit (Qiagen,
Germany) according to the manufacturer’s instructions. ERIC-PCR
was carried out as described by Steinbruechner et al.13
Ribotyping
C. diphtheriae strains isolated in 2004–2008 were ribotyped
according to von Hunolstein et al.2
Plasmid isolation
Two methods were used for plasmid isolation: alkaline lysis
according to Sambrook and Russel14 and a commercial kit –
Plazmid Mini (A&A Biotechnology, Poland). As a control we used
Escherichia coli V517 strain, which possesses eight cryptic plasmids
of different sizes.
Antimicrobial susceptibility testing
The minimum inhibitory concentrations (MICs) to 14
antibiotics and chemotherapeutics were determined by the E-
test method (AB Biodisk, Sweden) on Mueller–Hinton sheep
blood agar plates in accordance with the manufacturer’s
instructions and Clinical and Laboratory Standards Institute
(CLSI) guidelines.15 A direct colony suspension equivalent to a
0.5 McFarland standard was inoculated onto the plates for all
antibiotics and chemotherapeutics used in the test. For
intermediate strains the test was repeated with an inoculum
of density 1 McFarland. Results were interpreted according to
CLSI standards.15
Dendrograms
Data analysis was performed with GelCompar II 5.0
for Windows (AppliedMaths). Dendrograms were constructed
by the unweighted pair group method with arithmetic
averages (UPGMA), using Dice correlation (with an optimization
of 1.5% and a position tolerance of 1.5%). The computer-assisted
analysis was performed according to the manufacturer’s
instructions.
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Biotyping and toxigenicity testing
Results of biotyping and toxigenicity testing are presented in
Table 1, together with information about region of origin, site and
year of isolation of each C. diphtheriae strain investigated, as well as
PFGE and ERIC-PCR proﬁles.[(Figure_1)TD$FIG]
Figure 1. Dendrograms showing similarity of PFGE and ERIC-PPFGE
A total of 12 DNA proﬁles were identiﬁed in the entire strains
collection (Figure 1). All but two strains isolated in 2004–2008
belonged to the same PFGE type (type A). The two strains differed
only in one DNA band (pulsotypes A1 and A2). For ﬁve strains
isolated in the 1960s, PFGE types correlated with biotype. Three
strains belonging to biotypemitiswere classiﬁed as a type C or C1.CR patterns of tested Corynebacterium diphtheriae strains.
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as types G and H, respectively. For four strains isolated in the
1990s, three different PFGE types were obtained. However, two of
them differed only in one band in the DNA proﬁle (pulsotypes B
and B1) although the strains belonged to two biotypes. On the
other hand, two strains classiﬁed as pulsotype B belonged to
different biotypes. Strains isolated in 2000 and 2001 revealed two
PFGE types (types E and D, respectively), which were not similar to
any other PFGE types. Similarity between non-toxigenic strains
isolated in 2004–2008 and strains isolated form past diphtheria
outbreaks was below 73% in this typing method.
ERIC-PCR typing
Analysis of ERIC-PCR patterns showed a total of 11 different
patterns (Figure 1). The bands ranged in size from <250 bp to
3500 bp. All but one strain isolated in 2004–2008 revealed
indistinguishable patterns of DNA bands. All the mitis strains
isolated in the 1960s also revealed identical ﬁngerprints. Three of
four strains isolated in the 1990s showed ﬁngerprints differing in
only 1 or 2 DNA bands. Similarity between non-toxigenic strains
isolated in 2004–2008 and strains isolated in 60s, 90s and 2000–
2001 was 78% except the strain 6/B where similarity was 92%.
Ribotyping
Non-toxigenic C. diphtheriae strains isolated during 2004–2008
revealed indistinguishable ribotype patterns.
Plasmid isolation
No plasmids were detected in any of the C. diphtheriae strains.
Antimicrobial susceptibility
Table 2 shows the MIC range obtained for investigated strains.
All strains were susceptible to all antimicrobial agents tested
except cefotaxime and ciproﬂoxacin. All the strains isolated in the
1960s, as well as one strain isolated in the 1990s (6/B) and three
strains isolated in the 2000s (11/D, 12/E, 14/E), were intermediate
for cefotaxime. Strain 11/Dwas also intermediate for ciproﬂoxacin.
No difference in results was observed between tests prepared with
a suspension of density 0.5 McFarland and 1 McFarland. For all
other antimicrobial agents, all the strains were susceptible.
Discussion
In countries where anti-diphtheria vaccination is regularly
implemented, the spectrumof diseases caused by C. diphtheriaehasTable 2
Antimicrobial susceptibility of tested Corynebacterium diphtheriae strains
Antibiotic/chemotherapeutic Range of MICs
Benzylpenicillin <0.016–0.38
Cefotaxime 0.047–3
Imipenem 0.008–0.094
Vancomycin 0.5–1
Daptomycin 0.023–0.38
Gentamicin 0.064–0.75
Erythromycin <0.016–0.047
Ciproﬂoxacin 0.047–1.5
Tetracycline 0.125–0.75
Clindamycin 0.047–0.5
Trimethoprim/sulfamethoxazole 0.023–0.125
Rifampin <0.002–0.004
Quinupristin/dalfopristin 0.094–0.25
Linezolid 0.047–0.5
MIC, minimum inhibitory concentration.changed. Non-toxigenic isolates of C. diphtheriae have become
prevalent. Although diphtheria toxin is regarded as the main
virulence factor of C. diphtheriae, invasive infections caused by
non-toxigenic isolates suggest that these strains may possess
additional virulence factors. It is possible that the success in
preventing toxin-mediated disease as a result of the diphtheria
vaccine has caused selective pressure, which has forced C.
diphtheriae to express or develop means of causing disease and
virulence factors other than toxin-linked molecular mechanisms.
Severe and often fatal systemic diseases caused by non-toxigenic C.
diphtheriae, which were previously quite rare, have been docu-
mented in various countries during recent years. The vaccination
coverage in Poland is over 95%;16 and here too, changes in the
disease spectrum of C. diphtheriae have been noticed. The last cases
of diphtheria in Poland were recorded in 2000 (one case) and in
1996 (nine cases). From 1997 to 2003 no C. diphtheriae strains were
isolated in the area of Poland. Non-toxigenic C. diphtheriae
infections emerged from 2004. Hence there is a need to determine
the source of these C. diphtheriae strains and their means of spread.
Epidemiologically unrelated C. diphtheriae strains isolated in
2004–2008 in Poland were not distinguished by PFGE method,
although this method has been established as a highly reproduc-
ible and discriminatory molecular typing method for a wide range
of clinically and epidemiologically signiﬁcant bacterial patho-
gens.17 Moreover, the strains were also indistinguishable by
ribotyping – the method regarded as the most discriminatory and
‘gold standard’ for C. diphtheriae typing.12 To conﬁrm these
surprising results we decided to use another molecular typing
method: ERIC-PCR. Although sequence data for ERIC elements have
been described only from Gram-negative enteric bacteria and
closely related phyla, complex ERIC-PCR patterns can be readily
produced not only from the DNA of various bacteria, but also from
the DNA of bacteriophage and eukaryotes.18 This paper is the ﬁrst
publication describing the use of ERIC-PCR for C. diphtheriae typing.
In our results, PFGE and ERIC-PCR were able to discriminate the
strains at the same level. It is of note that the non-toxigenic C.
diphtheriae strains isolated in 2004–2008 in Poland are genetically
very closely related, and most of them are indistinguishable by
both genotyping methods used, despite different times and places
of isolation. Moreover, no differences were observed between
strains isolated from invasive and local infections. It has been
documented that endemic strains of toxigenic C. diphtheriae can
circulate within certain communities for over 25 years.19 However,
there are no data available about the circulation of non-toxigenic
strains. From the results of our investigation it is difﬁcult to ﬁnd
genetic similarity between strains isolated in 2004–2008 and
strains isolated in the 1960s, 1990s, 2000 and 2001. However,most
of the ‘old’ strains were toxigenic.
In each country where non-toxigenic C. diphtheriae infections
have been noticed, the dominance of a speciﬁc clone or biotype has
been observed, but always accompanied by the presence of other
clones or biotypes.1–3,5,6 In contrast, strains isolated in Poland
belong to the same clone and biotype, despite being isolated at
different times and from different parts of Poland (Table 1), and
without any epidemiological links. The results of genotyping of
these strains may be considered alarming because, as has been
observed by other authors, the dominance of one clone usually
precedes the onset of an epidemic. The prevalence of epidemic
strains belonging to a speciﬁc biotype or genotype has been shown
to be characteristic of each epidemic cycle of diphtheria.20,21 A
probable explanation for this is that epidemic strains have an
unidentiﬁed selective advantage. Also the increase in a number of
non-toxigenic C. diphtheriae infections, especially invasive infec-
tions, might suggest the acquisition of additional virulence factors.
In support of this theory is the isolation of one clone from the
infections analyzed in the present work. One possibility is the
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pathogenicity is connected with the presence of virulence
plasmids.22 Nevertheless, there are no publications available
concerning research into virulence plasmids in C. diphtheriae. In
our study we did not ﬁnd any plasmids in the investigated C.
diphtheriae strains. This points to other possibilities, such as the
presence of transposons, pathogenicity islands, or prophages in
chromosomes of the strains. There are plans to study these aspects
in the future.
In addition to the virulence properties of a bacterial strain, host
factors may contribute to the outcome of invasive infections. As
has been noticed by other authors, the main predisposing factors
for colonization and infection with non-toxigenic C. diphtheriae
are: intravenous drug use, low socioeconomic conditions com-
pounded by alcoholism and homelessness, and diabetes melli-
tus.1,3,5,6 We also noticed an additional risk factor for invasive
infections that has not yet beenmentioned by other authors – poor
dental condition.
Due to the high fatality rate of C. diphtheriae infections,
appropriate antimicrobial treatment is crucial. Penicillin and
erythromycin have been the drugs of choice for the eradication
of toxigenic strains of C. diphtheriae from symptomatic patients,
close contacts, and asymptomatic carriers. These drugs are also
often used in the treatment of non-toxigenic C. diphtheriae
infections. However, isolates resistant to b-lactams and erythro-
mycin have been described.23,24 Moreover, multidrug-resistant C.
diphtheriae strains have also been isolated.25 It is worth noting that
all strains tested in this work were susceptible to penicillin and
erythromycin. In general, the susceptibilities of the strains in the
present study were found to be a little higher than those reported
for most antibiotics in other studies.1,2,25,26 In contrast to other
studies, no isolates tested in the present work were found to be
resistant to benzylpenicillin, imipenem, vancomycin, daptomycin,
gentamicin, erythromycin, tetracycline, clindamycin, trimetho-
prim/sulfamethoxazole, rifampin, quinupristin/dalfopristin, and
linezolid. Only one strain was intermediate for ciproﬂoxacin.
Forty-seven percent (9/19) of strains were intermediate for
cefotaxime. von Hunolstein et al.2 revealed that strains isolated
in Italy in the 1990 s were all intermediate for cefotaxime. These
results would suggest that cefotaxime is not the best choice of drug
for the therapy of C. diphtheriae infections when the susceptibility
pattern of the isolate is not known. On the other hand, Patey et al.1
analyzed antimicrobial susceptibility of non-toxigenic C. diphther-
iae strains isolated in France and stated that among the broad-
spectrum cephalosporins only cefotaxime and ceftriaxone were
always dependable. Although signiﬁcant antimicrobial resistance
remains rare amongst C. diphtheriae, it appears to be important to
control antimicrobial susceptibility of emerging C. diphtheriae
strains. Appropriate antimicrobial therapy is crucial in infections
and could be life-saving in invasive C. diphtheriae infections.
In Poland, as in manyWestern countries, the rarity of toxigenic
diphtheria has prompted laboratories to abandon the screening of
throat swabs for C. diphtheriae. As a consequence, the level of
carriage is not known. Vaccination protects against the effects of
the toxin but does not protect against carriage or non-toxigenic
infections.Moreover, there are no available data on anti-diphtheria
antibody levels in the Polish population, particularly in adults.
Althoughmore than 95% of children receive three doses of an anti-
diphtheria vaccine, it is known that the antibody level decreases
over time and that most adults in the population probably do not
have a protective level of anti-diphtheria antibodies.16,27 Monitor-
ing the spread of C. diphtheriae strains is very important because
the risk of importation of toxigenic strains from Eastern Europe
and other diphtheria endemic regions still exists. In the face of an
increase in the number of non-toxigenic C. diphtheriae infections it
is also necessary to monitor the spread of non-toxigenic strains.Moreover, it is also important to monitor molecular changes in
circulating strains that may increase invasiveness and pathoge-
nicity.
On the basis of the results presented in this work, it may be
concluded that PFGE and ERIC-PCR are able to discriminate C.
diphtheriae strains at the same level. As ERIC-PCR is less time-
consuming and labor intensive than PFGE it could be used when
time is of the essence or when analyzing a large group of strains is
necessary. However, we have to remember that the reproducibility
of ERIC-PCR is limited. The limitation could be minimized by the
use of one mastermix for all PCRs.
In summary, the number of non-toxigenic C. diphtheriae
invasive infections has been seen to increase in many countries
with high diphtheria vaccination coverage. Studies of genetic
similarity presented in this work, as well as by other authors, point
to new emerging invasive clones. The higher invasiveness of the
strains is not associated with virulence plasmids, but rather with
other genetic elements located in a chromosome, which need to be
investigated. If the number of non-toxigenic C. diphtheriae invasive
infections constantly increases, the production and introduction of
a new vaccine against non-toxigenic C. diphtheriae should be
considered.
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